| dbo:abstract
|
- Delix Therapeutics is an American biotech company based in Boston, Massachusetts. The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD). It was co-founded in 2019 by David E. Olson and Nick Haft. (en)
|
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 6128 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founded
| |
| dbp:hqLocation
|
- Boston, Massachusetts (en)
|
| dbp:industry
| |
| dbp:keyPeople
| |
| dbp:name
|
- Delix Therapeutics, Inc. (en)
|
| dbp:type
| |
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| dct:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Delix Therapeutics is an American biotech company based in Boston, Massachusetts. The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD). It was co-founded in 2019 by David E. Olson and Nick Haft. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Delix Therapeutics, Inc. ("Delix") (en)
|
| is dbo:employer
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
